Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Edge Therapeutics (EDGE) Competitors

Edge Therapeutics logo

EDGE vs. PBH, RYTM, PRGO, PTCT, CYTK, RNA, SRPT, RARE, AKRO, and ZLAB

Should you be buying Edge Therapeutics stock or one of its competitors? The main competitors of Edge Therapeutics include Prestige Consumer Healthcare (PBH), Rhythm Pharmaceuticals (RYTM), Perrigo (PRGO), PTC Therapeutics (PTCT), Cytokinetics (CYTK), Avidity Biosciences (RNA), Sarepta Therapeutics (SRPT), Ultragenyx Pharmaceutical (RARE), Akero Therapeutics (AKRO), and Zai Lab (ZLAB). These companies are all part of the "medical" sector.

Edge Therapeutics vs.

Edge Therapeutics (NASDAQ:EDGE) and Prestige Consumer Healthcare (NYSE:PBH) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, community ranking, analyst recommendations, institutional ownership, media sentiment, profitability and earnings.

Edge Therapeutics has a beta of 3.65, suggesting that its share price is 265% more volatile than the S&P 500. Comparatively, Prestige Consumer Healthcare has a beta of 0.44, suggesting that its share price is 56% less volatile than the S&P 500.

Prestige Consumer Healthcare received 321 more outperform votes than Edge Therapeutics when rated by MarketBeat users. Likewise, 70.14% of users gave Prestige Consumer Healthcare an outperform vote while only 66.79% of users gave Edge Therapeutics an outperform vote.

CompanyUnderperformOutperform
Edge TherapeuticsOutperform Votes
177
66.79%
Underperform Votes
88
33.21%
Prestige Consumer HealthcareOutperform Votes
498
70.14%
Underperform Votes
212
29.86%

Prestige Consumer Healthcare has higher revenue and earnings than Edge Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edge TherapeuticsN/AN/A-$40.86MN/AN/A
Prestige Consumer Healthcare$1.14B3.73$209.34M$4.2920.04

In the previous week, Prestige Consumer Healthcare had 8 more articles in the media than Edge Therapeutics. MarketBeat recorded 9 mentions for Prestige Consumer Healthcare and 1 mentions for Edge Therapeutics. Prestige Consumer Healthcare's average media sentiment score of 1.38 beat Edge Therapeutics' score of 0.00 indicating that Prestige Consumer Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Edge Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Prestige Consumer Healthcare
7 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Prestige Consumer Healthcare has a consensus price target of $93.33, suggesting a potential upside of 8.55%. Given Prestige Consumer Healthcare's stronger consensus rating and higher probable upside, analysts clearly believe Prestige Consumer Healthcare is more favorable than Edge Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Edge Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Prestige Consumer Healthcare
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

28.0% of Edge Therapeutics shares are held by institutional investors. Comparatively, 99.9% of Prestige Consumer Healthcare shares are held by institutional investors. 37.1% of Edge Therapeutics shares are held by insiders. Comparatively, 1.6% of Prestige Consumer Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Prestige Consumer Healthcare has a net margin of 19.13% compared to Edge Therapeutics' net margin of 0.00%. Prestige Consumer Healthcare's return on equity of 12.36% beat Edge Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Edge TherapeuticsN/A -81.29% -56.92%
Prestige Consumer Healthcare 19.13%12.36%6.39%

Summary

Prestige Consumer Healthcare beats Edge Therapeutics on 13 of the 15 factors compared between the two stocks.

Get Edge Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for EDGE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EDGE vs. The Competition

MetricEdge TherapeuticsPharmaceutical Preparations IndustryMedical SectorNASDAQ Exchange
Market Cap$1.19B$6.48B$5.33B$8.31B
Dividend YieldN/A2.64%5.20%4.10%
P/E RatioN/A8.4026.7219.60
Price / SalesN/A258.84395.56117.92
Price / CashN/A65.8538.3234.62
Price / Book39.596.416.764.50
Net Income-$40.86M$143.73M$3.23B$248.40M

Edge Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EDGE
Edge Therapeutics
N/A$37.61
0.0%
N/A+956.7%$1.19BN/A0.00N/A
PBH
Prestige Consumer Healthcare
3.6841 of 5 stars
$87.11
+2.0%
$93.33
+7.1%
+31.1%$4.32B$1.14B20.40540Positive News
RYTM
Rhythm Pharmaceuticals
3.9232 of 5 stars
$60.18
+5.1%
$75.38
+25.3%
+63.9%$3.83B$136.86M-13.90140Positive News
PRGO
Perrigo
4.6201 of 5 stars
$26.30
+1.1%
$33.00
+25.5%
-10.0%$3.62B$4.34B-22.488,900Positive News
PTCT
PTC Therapeutics
4.172 of 5 stars
$45.31
-3.1%
$61.92
+36.7%
+17.8%$3.59B$1.77B-7.631,410Gap Down
High Trading Volume
CYTK
Cytokinetics
4.0292 of 5 stars
$29.84
-0.5%
$74.44
+149.5%
-48.5%$3.56B$19.22M-5.55250
RNA
Avidity Biosciences
1.9359 of 5 stars
$28.97
+2.0%
$66.38
+129.1%
+4.0%$3.49B$10.90M-10.06190Gap Down
SRPT
Sarepta Therapeutics
4.7645 of 5 stars
$35.27
-1.3%
$126.74
+259.3%
-69.8%$3.47B$2.23B28.22840Analyst Forecast
Gap Down
High Trading Volume
RARE
Ultragenyx Pharmaceutical
3.9401 of 5 stars
$34.84
+0.3%
$90.93
+161.0%
-13.6%$3.29B$590.69M-5.501,310Gap Up
AKRO
Akero Therapeutics
3.7851 of 5 stars
$39.96
+5.5%
$82.33
+106.0%
+138.9%$3.18BN/A-10.6630Gap Down
ZLAB
Zai Lab
2.5997 of 5 stars
$28.75
+2.2%
$47.37
+64.8%
+61.2%$3.17B$418.33M-10.381,950

Related Companies and Tools


This page (NASDAQ:EDGE) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners